Vaxart, Inc. Net Income
Vaxart, Inc. (VXRT) reported Net Income of -$13.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-06
- Vaxart, Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$13.49M.
- Vaxart, Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was $5.18M.
- Vaxart, Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was $38.73M, a 29.44% decline year-over-year.
- Vaxart, Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$8.14M.
- Vaxart, Inc. net income (loss) attributable to parent for fiscal 2022 was -$107.76M.
- Vaxart, Inc. net income (loss) attributable to parent for fiscal 2021 was -$70.47M.
- Vaxart, Inc. net income (loss) attributable to parent for fiscal 2020 was -$32.22M.
- Vaxart, Inc. net income (loss) attributable to parent for fiscal 2019 was -$18.64M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$13.49M 10-Q · filed 2026-08-06 | -$8.31M 10-Q · filed 2026-08-06 | $30.42M derived: sum of 3 quarters · filed 2026-08-06 | $22.28M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $5.18M S-1 · filed 2026-05-08 | $43.91M derived: sum of 2 quarters · filed 2026-06-01 | $35.77M derived: sum of 3 quarters · filed 2026-06-01 | $20.79M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $38.73M derived: DEFC14A 12 month − 10-Q 9 month · filed 2026-06-01 | $30.59M derived: sum of 2 quarters · filed 2026-06-01 | $15.61M derived: sum of 3 quarters · filed 2026-08-06 | $16.33K DEFC14A · filed 2026-06-01 | $16.33M 10-K · filed 2026-03-13 | |||
| 2025-09-30 | -$8.14M 10-Q · filed 2025-11-13 | -$23.13M derived: sum of 2 quarters · filed 2026-08-06 | -$38.72M 10-Q · filed 2025-11-13 | $16.18M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$14.99M 10-Q · filed 2026-08-06 | -$30.58M 10-Q · filed 2026-08-06 | $24.32M derived: sum of 3 quarters · filed 2026-08-06 | $10.24M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$15.59M S-1 · filed 2026-05-08 | $39.31M derived: sum of 2 quarters · filed 2026-06-01 | $25.23M derived: sum of 3 quarters · filed 2026-06-01 | $8.76M derived: sum of 4 quarters · filed 2026-06-01 | ||||
| 2024-12-31 | $54.90M derived: DEFC14A 12 month − 10-Q 9 month · filed 2026-06-01 | $40.82M derived: sum of 2 quarters · filed 2026-06-01 | $24.35M derived: sum of 3 quarters · filed 2026-06-01 | -$66.95K DEFC14A · filed 2026-06-01 | -$66.95M 10-K · filed 2025-03-20 | |||
| 2024-09-30 | -$14.08M 10-Q · filed 2025-11-13 | -$30.55M derived: sum of 2 quarters · filed 2025-11-13 | -$54.96M 10-Q · filed 2025-11-13 | $10.04M derived: sum of 4 quarters · filed 2026-06-01 | ||||
| 2024-06-30 | -$16.47M 10-Q · filed 2025-08-13 | -$40.88M 10-Q · filed 2025-08-13 | $24.12M derived: sum of 3 quarters · filed 2026-06-01 | $6.72M derived: sum of 4 quarters · filed 2026-06-01 | ||||
| 2024-03-31 | -$24.42M 10-Q · filed 2025-05-13 | $40.59M derived: sum of 2 quarters · filed 2026-06-01 | $23.19M derived: sum of 3 quarters · filed 2026-06-01 | $640.53K derived: sum of 4 quarters · filed 2026-06-01 | ||||
| 2023-12-31 | $65.01M derived: DEFC14A 12 month − 10-Q 9 month · filed 2026-06-01 | $47.61M derived: sum of 2 quarters · filed 2026-06-01 | $25.06M derived: sum of 3 quarters · filed 2026-06-01 | -$82.47K DEFC14A · filed 2026-06-01 | -$82.47M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | -$17.40M 10-Q · filed 2024-11-13 | -$39.95M derived: sum of 2 quarters · filed 2024-11-13 | -$65.09M 10-Q · filed 2024-11-13 | -$89.01M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$22.55M 10-Q · filed 2024-08-08 | -$47.69M 10-Q · filed 2024-08-08 | -$71.61M derived: sum of 3 quarters · filed 2024-08-08 | -$100.92M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$25.14M 10-Q · filed 2024-05-13 | -$49.06M derived: sum of 2 quarters · filed 2024-05-13 | -$78.37M derived: sum of 3 quarters · filed 2024-05-13 | -$107.80M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -$23.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$53.23M derived: sum of 2 quarters · filed 2024-03-14 | -$82.66M derived: sum of 3 quarters · filed 2024-03-14 | -$107.76M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$29.31M 10-Q · filed 2023-11-02 | -$58.74M derived: sum of 2 quarters · filed 2023-11-02 | -$83.84M 10-Q · filed 2023-11-02 | -$104.60M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | -$29.43M 10-Q · filed 2023-08-03 | -$54.53M 10-Q · filed 2023-08-03 | -$75.30M derived: sum of 3 quarters · filed 2023-08-03 | -$92.88M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$25.10M 10-Q · filed 2023-05-04 | -$45.87M derived: sum of 2 quarters · filed 2023-05-04 | -$63.45M derived: sum of 3 quarters · filed 2023-05-04 | -$79.56M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$20.76M 10-K · filed 2022-02-24 | -$38.35M derived: sum of 2 quarters · filed 2022-11-09 | -$54.46M derived: sum of 3 quarters · filed 2022-11-09 | -$70.47M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | -$17.58M 10-Q · filed 2022-11-09 | -$33.70M derived: sum of 2 quarters · filed 2022-11-09 | -$49.71M 10-Q · filed 2022-11-09 | -$63.57M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$16.12M 10-Q · filed 2022-08-08 | -$32.12M 10-Q · filed 2022-08-08 | -$45.98M derived: sum of 3 quarters · filed 2022-08-08 | -$54.07M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | -$16.01M 10-Q · filed 2022-05-09 | -$29.87M derived: sum of 2 quarters · filed 2022-05-09 | -$37.95M derived: sum of 3 quarters · filed 2022-05-09 | -$46.93M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | -$13.86M 10-K · filed 2022-02-24 | -$21.95M derived: sum of 2 quarters · filed 2022-02-24 | -$30.92M derived: sum of 3 quarters · filed 2022-02-24 | -$32.22M 10-K · filed 2022-02-24 | ||||
| 2020-09-30 | -$8.09M 10-K · filed 2022-02-24 | -$17.06M derived: sum of 2 quarters · filed 2022-02-24 | -$18.36M 10-Q · filed 2021-11-04 | -$24.77M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$8.98M 10-K · filed 2022-02-24 | -$10.27M 10-Q · filed 2021-08-05 | -$16.68M derived: sum of 3 quarters · filed 2022-02-24 | -$21.94M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$1.30M 10-K · filed 2022-02-24 | -$7.71M derived: sum of 2 quarters · filed 2022-02-24 | -$12.97M derived: sum of 3 quarters · filed 2022-02-24 | -$18.60M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$6.41M 10-K · filed 2022-02-24 | -$11.67M derived: sum of 2 quarters · filed 2022-02-24 | -$17.31M derived: sum of 3 quarters · filed 2022-02-24 | -$18.64M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$5.26M 10-K · filed 2022-02-24 | -$10.90M derived: sum of 2 quarters · filed 2022-02-24 | -$12.24M 10-Q · filed 2020-11-12 | -$17.14M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-06-30 | -$5.64M 10-K · filed 2022-02-24 | -$6.98M 10-Q · filed 2020-08-06 | -$11.88M derived: sum of 3 quarters · filed 2022-02-24 | -$18.43M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-03-31 | -$1.34M 10-K · filed 2022-02-24 | -$6.24M derived: sum of 2 quarters · filed 2022-02-24 | -$12.79M derived: sum of 3 quarters · filed 2022-02-24 | -$21.66M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2018-12-31 | -$4.90M 10-K · filed 2021-02-25 | -$11.45M derived: sum of 2 quarters · filed 2021-02-25 | -$20.32M derived: sum of 3 quarters · filed 2021-02-25 | -$18.01M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$6.55M 10-K · filed 2021-02-25 | -$15.42M derived: sum of 2 quarters · filed 2021-02-25 | -$13.11M 10-Q · filed 2019-11-12 | -$14.18M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-06-30 | -$8.87M 10-K · filed 2021-02-25 | -$6.56M 10-Q · filed 2019-08-08 | -$7.63M derived: sum of 3 quarters · filed 2021-02-25 | -$9.80M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-03-31 | $2.31M 10-K · filed 2021-02-25 | $1.24M derived: sum of 2 quarters · filed 2021-02-25 | -$934.00K derived: sum of 3 quarters · filed 2021-02-25 | -$4.47M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2017-12-31 | -$1.07M 10-K · filed 2019-02-06 | -$3.40M 10-Q · filed 2018-02-06 | -$8.70M 10-Q · filed 2018-02-06 | -$6.79M derived: sum of 3 quarters · filed 2019-02-06 | -$9.58M 10-K · filed 2019-02-06 | |||
| 2017-09-30 | -$2.17M 10-K · filed 2019-02-06 | -$5.30M 10-Q · filed 2017-11-07 | -$5.71M derived: sum of 2 quarters · filed 2019-02-06 | -$8.51M 10-Q · filed 2018-11-13 | -$17.61M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2017-06-30 | -$3.54M 10-K · filed 2019-02-06 | -$6.33M 10-Q · filed 2018-08-10 | -$15.43M derived: sum of 3 quarters · filed 2019-02-06 | -$29.40M 10-K · filed 2017-09-01 | ||||
| 2017-03-31 | -$2.80M 10-K · filed 2019-02-06 | -$4.40M 10-Q · filed 2017-05-08 | -$11.90M derived: sum of 2 quarters · filed 2019-02-06 | -$23.50M 10-Q · filed 2017-05-08 | -$29.00M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2016-12-31 | -$9.10M 10-Q · filed 2018-02-06 | -$19.10M 10-Q · filed 2018-02-06 | -$26.20M derived: sum of 3 quarters · filed 2018-02-06 | -$31.40M derived: sum of 4 quarters · filed 2018-02-06 | ||||
| 2016-09-30 | -$10.00M 10-Q · filed 2017-11-07 | -$17.10M derived: sum of 2 quarters · filed 2017-11-07 | -$22.30M derived: sum of 3 quarters · filed 2017-11-07 | -$28.80M derived: sum of 4 quarters · filed 2017-11-07 | ||||
| 2016-06-30 | -$7.10M 10-K · filed 2016-09-13 | -$12.30M derived: sum of 2 quarters · filed 2017-05-08 | -$18.80M derived: sum of 3 quarters · filed 2017-05-08 | -$25.40M 10-K · filed 2017-09-01 | ||||
| 2016-03-31 | -$5.20M 10-Q · filed 2017-05-08 | -$11.70M derived: sum of 2 quarters · filed 2017-05-08 | -$18.40M 10-Q · filed 2017-05-08 | -$38.20M derived: sum of 4 quarters · filed 2017-05-08 | ||||
| 2015-12-31 | -$6.50M 10-Q · filed 2017-02-06 | -$13.20M 10-Q · filed 2017-02-06 | -$33.00M derived: sum of 3 quarters · filed 2017-02-06 | -$31.80M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2015-09-30 | -$6.60M 10-Q · filed 2016-11-08 | -$26.50M derived: sum of 2 quarters · filed 2016-11-08 | -$25.30M derived: sum of 3 quarters · filed 2016-11-08 | -$18.80M derived: sum of 4 quarters · filed 2016-11-08 | ||||
| 2015-06-30 | -$19.90M 10-K · filed 2016-09-13 | -$18.70M derived: sum of 2 quarters · filed 2016-09-13 | -$12.20M derived: sum of 3 quarters · filed 2016-09-13 | -$19.10M 10-K · filed 2016-09-13 | ||||
| 2015-03-31 | $1.20M 10-K · filed 2016-09-13 | $7.70M derived: sum of 2 quarters · filed 2016-09-13 | $800.00K 10-Q · filed 2016-05-10 | -$9.40M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-12-31 | $6.50M 10-K · filed 2016-09-13 | -$400.00K 10-Q · filed 2016-02-08 | -$10.60M derived: sum of 3 quarters · filed 2016-09-13 | -$7.40M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-09-30 | -$6.90M 10-K · filed 2016-09-13 | -$17.10M derived: sum of 2 quarters · filed 2016-09-13 | -$13.90M derived: sum of 3 quarters · filed 2016-09-13 | -$14.00M derived: sum of 4 quarters · filed 2016-09-13 | ||||
| 2014-06-30 | -$10.20M 10-K · filed 2015-09-11 | -$7.00M derived: sum of 2 quarters · filed 2015-09-11 | -$7.10M derived: sum of 3 quarters · filed 2015-09-11 | -$11.00M 10-K · filed 2016-09-13 | ||||
| 2014-03-31 | $3.20M 10-K · filed 2015-09-11 | $3.10M derived: sum of 2 quarters · filed 2015-09-11 | -$800.00K 10-Q · filed 2015-05-08 | -$7.30M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-12-31 | -$100.00K 10-K · filed 2015-09-11 | -$4.00M 10-Q · filed 2015-02-06 | -$10.50M derived: sum of 3 quarters · filed 2015-09-11 | -$10.30M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-09-30 | -$3.90M 10-K · filed 2015-09-11 | -$10.40M derived: sum of 2 quarters · filed 2015-09-11 | -$10.20M derived: sum of 3 quarters · filed 2015-09-11 | -$5.60M derived: sum of 4 quarters · filed 2015-09-11 | ||||
| 2013-06-30 | -$6.50M 10-K · filed 2014-09-30 | -$6.30M derived: sum of 2 quarters · filed 2014-09-30 | -$1.70M derived: sum of 3 quarters · filed 2014-09-30 | -$8.90M 10-K · filed 2015-09-11 | -$8.70M 10-K · filed 2013-09-27 | |||
| 2013-03-31 | $200.00K 10-K · filed 2014-09-30 | $215.00K 10-Q · filed 2013-05-10 | $4.80M derived: sum of 2 quarters · filed 2014-09-30 | -$2.40M 10-Q · filed 2014-05-12 | -$2.20M 10-Q · filed 2013-05-10 | -$5.13M derived: sum of 4 quarters · filed 2014-09-30 | ||
| 2012-12-31 | $4.60M 10-K · filed 2014-09-30 | $4.83M 10-Q · filed 2013-02-11 | -$2.60M 10-Q · filed 2014-02-10 | -$2.41M 10-Q · filed 2013-02-11 | -$5.33M derived: sum of 3 quarters · filed 2014-09-30 | -$7.37M derived: sum of 4 quarters · filed 2014-09-30 | ||
| 2012-09-30 | -$7.20M 10-K · filed 2014-09-30 | -$4.09M 10-Q · filed 2012-11-08 | -$9.93M derived: sum of 2 quarters · filed 2014-09-30 | -$7.26M 10-Q · filed 2012-11-08 | -$19.02M derived: sum of 4 quarters · filed 2014-09-30 | |||
| 2012-06-30 | -$2.73M 10-Q · filed 2012-08-09 | -$3.17M 10-Q · filed 2012-08-09 | -$11.82M derived: sum of 3 quarters · filed 2013-05-10 | -$19.20M 10-K · filed 2014-09-30 | ||||
| 2012-03-31 | -$2.04M 10-Q · filed 2013-05-10 | -$436.00K 10-Q · filed 2012-05-10 | -$9.09M derived: sum of 2 quarters · filed 2013-05-10 | -$13.29M 10-Q · filed 2013-05-10 | -$13.61M derived: sum of 4 quarters · filed 2013-05-10 | |||
| 2011-12-31 | -$7.05M 10-Q · filed 2013-02-11 | -$11.25M 10-Q · filed 2013-02-11 | -$11.58M derived: sum of 3 quarters · filed 2013-02-11 | -$4.53M 10-K · filed 2012-03-14 | ||||
| 2011-09-24 | $78.00K 10-Q · filed 2012-11-08 | -$4.52M derived: sum of 2 quarters · filed 2012-08-09 | -$2.54M 10-Q · filed 2012-11-08 | -$8.87M derived: sum of 4 quarters · filed 2012-08-09 | ||||
| 2011-06-30 | -$25.40M 10-K · filed 2013-09-27 | |||||||
| 2011-06-25 | -$4.60M 10-Q · filed 2012-08-09 | -$2.62M 10-Q · filed 2012-08-09 | -$8.95M derived: sum of 3 quarters · filed 2012-08-09 | -$3.81M derived: sum of 4 quarters · filed 2012-08-09 | ||||
| 2011-03-26 | $1.98M 10-Q · filed 2012-05-10 | -$4.35M derived: sum of 2 quarters · filed 2012-05-10 | $784.00K derived: sum of 3 quarters · filed 2012-05-10 | -$2.62M derived: sum of 4 quarters · filed 2012-05-10 | ||||
| 2010-12-25 | -$6.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | -$1.20M derived: sum of 2 quarters · filed 2012-03-14 | -$4.60M derived: sum of 3 quarters · filed 2012-03-14 | $878.00K 10-K · filed 2012-03-14 | ||||
| 2010-09-25 | $5.13M 10-Q · filed 2011-11-02 | $1.73M derived: sum of 2 quarters · filed 2011-11-02 | $7.21M 10-Q · filed 2011-11-02 | |||||
| 2010-06-26 | -$3.41M 10-Q · filed 2011-08-03 | $2.07M 10-Q · filed 2011-08-03 | ||||||
| 2009-12-26 | -$18.73M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |